Research ArticleArticle
Nonclassical Ligand-Independent Regulation of Go Protein by an Orphan Class C G-Protein–Coupled Receptor
Mariana Hajj, Teresa De Vita, Claire Vol, Charlotte Renassia, Jean-Charles Bologna, Isabelle Brabet, Magali Cazade, Manuela Pastore, Jaroslav Blahos, Gilles Labesse, Jean-Philippe Pin and Laurent Prézeau
Molecular Pharmacology August 2019, 96 (2) 233-246; DOI: https://doi.org/10.1124/mol.118.113019
Mariana Hajj
Institute of Functional Genomics (M.H., T.D.V., C.V., C.R., J.-C.B., I.B., M.C., M.P., J.-P.P., L.P.) and CBS (G.L.), University of Montpellier, French National Center for Scientific Research (CNRS), French National Institute of Health and Medicine (INSERM), Montpellier, France; and Institute of Molecular Genetics, Academy of Sciences of the Czech Republic and Department of Pharmacology, 2nd Medical School, Charles University, Prague, Czech Republic (J.B.)
Teresa De Vita
Institute of Functional Genomics (M.H., T.D.V., C.V., C.R., J.-C.B., I.B., M.C., M.P., J.-P.P., L.P.) and CBS (G.L.), University of Montpellier, French National Center for Scientific Research (CNRS), French National Institute of Health and Medicine (INSERM), Montpellier, France; and Institute of Molecular Genetics, Academy of Sciences of the Czech Republic and Department of Pharmacology, 2nd Medical School, Charles University, Prague, Czech Republic (J.B.)
Claire Vol
Institute of Functional Genomics (M.H., T.D.V., C.V., C.R., J.-C.B., I.B., M.C., M.P., J.-P.P., L.P.) and CBS (G.L.), University of Montpellier, French National Center for Scientific Research (CNRS), French National Institute of Health and Medicine (INSERM), Montpellier, France; and Institute of Molecular Genetics, Academy of Sciences of the Czech Republic and Department of Pharmacology, 2nd Medical School, Charles University, Prague, Czech Republic (J.B.)
Charlotte Renassia
Institute of Functional Genomics (M.H., T.D.V., C.V., C.R., J.-C.B., I.B., M.C., M.P., J.-P.P., L.P.) and CBS (G.L.), University of Montpellier, French National Center for Scientific Research (CNRS), French National Institute of Health and Medicine (INSERM), Montpellier, France; and Institute of Molecular Genetics, Academy of Sciences of the Czech Republic and Department of Pharmacology, 2nd Medical School, Charles University, Prague, Czech Republic (J.B.)
Jean-Charles Bologna
Institute of Functional Genomics (M.H., T.D.V., C.V., C.R., J.-C.B., I.B., M.C., M.P., J.-P.P., L.P.) and CBS (G.L.), University of Montpellier, French National Center for Scientific Research (CNRS), French National Institute of Health and Medicine (INSERM), Montpellier, France; and Institute of Molecular Genetics, Academy of Sciences of the Czech Republic and Department of Pharmacology, 2nd Medical School, Charles University, Prague, Czech Republic (J.B.)
Isabelle Brabet
Institute of Functional Genomics (M.H., T.D.V., C.V., C.R., J.-C.B., I.B., M.C., M.P., J.-P.P., L.P.) and CBS (G.L.), University of Montpellier, French National Center for Scientific Research (CNRS), French National Institute of Health and Medicine (INSERM), Montpellier, France; and Institute of Molecular Genetics, Academy of Sciences of the Czech Republic and Department of Pharmacology, 2nd Medical School, Charles University, Prague, Czech Republic (J.B.)
Magali Cazade
Institute of Functional Genomics (M.H., T.D.V., C.V., C.R., J.-C.B., I.B., M.C., M.P., J.-P.P., L.P.) and CBS (G.L.), University of Montpellier, French National Center for Scientific Research (CNRS), French National Institute of Health and Medicine (INSERM), Montpellier, France; and Institute of Molecular Genetics, Academy of Sciences of the Czech Republic and Department of Pharmacology, 2nd Medical School, Charles University, Prague, Czech Republic (J.B.)
Manuela Pastore
Institute of Functional Genomics (M.H., T.D.V., C.V., C.R., J.-C.B., I.B., M.C., M.P., J.-P.P., L.P.) and CBS (G.L.), University of Montpellier, French National Center for Scientific Research (CNRS), French National Institute of Health and Medicine (INSERM), Montpellier, France; and Institute of Molecular Genetics, Academy of Sciences of the Czech Republic and Department of Pharmacology, 2nd Medical School, Charles University, Prague, Czech Republic (J.B.)
Jaroslav Blahos
Institute of Functional Genomics (M.H., T.D.V., C.V., C.R., J.-C.B., I.B., M.C., M.P., J.-P.P., L.P.) and CBS (G.L.), University of Montpellier, French National Center for Scientific Research (CNRS), French National Institute of Health and Medicine (INSERM), Montpellier, France; and Institute of Molecular Genetics, Academy of Sciences of the Czech Republic and Department of Pharmacology, 2nd Medical School, Charles University, Prague, Czech Republic (J.B.)
Gilles Labesse
Institute of Functional Genomics (M.H., T.D.V., C.V., C.R., J.-C.B., I.B., M.C., M.P., J.-P.P., L.P.) and CBS (G.L.), University of Montpellier, French National Center for Scientific Research (CNRS), French National Institute of Health and Medicine (INSERM), Montpellier, France; and Institute of Molecular Genetics, Academy of Sciences of the Czech Republic and Department of Pharmacology, 2nd Medical School, Charles University, Prague, Czech Republic (J.B.)
Jean-Philippe Pin
Institute of Functional Genomics (M.H., T.D.V., C.V., C.R., J.-C.B., I.B., M.C., M.P., J.-P.P., L.P.) and CBS (G.L.), University of Montpellier, French National Center for Scientific Research (CNRS), French National Institute of Health and Medicine (INSERM), Montpellier, France; and Institute of Molecular Genetics, Academy of Sciences of the Czech Republic and Department of Pharmacology, 2nd Medical School, Charles University, Prague, Czech Republic (J.B.)
Laurent Prézeau
Institute of Functional Genomics (M.H., T.D.V., C.V., C.R., J.-C.B., I.B., M.C., M.P., J.-P.P., L.P.) and CBS (G.L.), University of Montpellier, French National Center for Scientific Research (CNRS), French National Institute of Health and Medicine (INSERM), Montpellier, France; and Institute of Molecular Genetics, Academy of Sciences of the Czech Republic and Department of Pharmacology, 2nd Medical School, Charles University, Prague, Czech Republic (J.B.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Atypical Ligand-Independent Control of Go by GPR158
Mariana Hajj, Teresa De Vita, Claire Vol, Charlotte Renassia, Jean-Charles Bologna, Isabelle Brabet, Magali Cazade, Manuela Pastore, Jaroslav Blahos, Gilles Labesse, Jean-Philippe Pin and Laurent Prézeau
Molecular Pharmacology August 1, 2019, 96 (2) 233-246; DOI: https://doi.org/10.1124/mol.118.113019
Research ArticleArticle
Atypical Ligand-Independent Control of Go by GPR158
Mariana Hajj, Teresa De Vita, Claire Vol, Charlotte Renassia, Jean-Charles Bologna, Isabelle Brabet, Magali Cazade, Manuela Pastore, Jaroslav Blahos, Gilles Labesse, Jean-Philippe Pin and Laurent Prézeau
Molecular Pharmacology August 1, 2019, 96 (2) 233-246; DOI: https://doi.org/10.1124/mol.118.113019
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement